Portfolio

GeneQuine (Teilexit) Exit

GeneQuine Biotherapeutics is a biotech company focused on the development of gene therapy-based drugs for treatment of musculoskeletal disorders. In the lead program GeneQuine develops drug candidates with potentially disease-modifying activity for treatment of osteoarthritis.
In 2017, one of GeneQuine's lead candidates was acquired by the US pharma company Flexion Therapeutics Inc.

Management

Dr. Stanislav Plutizki

Dr. Kilian Guse

Info & Contact

Address

Harburger Schlossstraße 6-12
21079 Hamburg

In portfolio

12. Oct 2012
Exit